MEDEXUS PHARMA
Medexus Pharma is a fully integrated specialty pharmaceutical company located in Chicago.
MEDEXUS PHARMA
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2012-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.medexus.com
Total Employee:
51+
Status:
Active
Contact:
312-854-0500
Total Funding:
42.12 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Amazon Office 365 Mail IPv6 Cloudflare JS CDN JS Amazon Virginia Region Amazon Route 53
Similar Organizations
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-22 | Aptevo Therapeutics | Aptevo Therapeutics acquired by Medexus Pharma | N/A |
Investors List
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Medexus Pharma
Official Site Inspections
http://www.medexus.com Semrush global rank: 4 M Semrush visits lastest month: 3.1 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Medexus Pharma" on Search Engine
Medexus Pharma Canada :: Medexus Pharmaceuticals, Inc. (MDP)
Medexus Pharma Canada is a Canadian-based specialty pharmaceutical company focused on the key areas of rheumatology, auto-immune disease, pediatrics, allergy, …See details»
Medexus Pharma USA :: Medexus Pharmaceuticals, Inc. (MDP)
Medexus Pharma USA is a wholly owned subsidiary of Medexus Pharmaceuticals, Inc. Based in Chicago, Illinois, Medexus Pharma USA focuses on the development and …See details»
Board of Directors :: Medexus Pharmaceuticals, Inc. (MDP)
Ken d’Entremont is the founder, president, and CEO of Medexus Inc. Previously, he was the general manager and vice president of business development at Sanofi, where he …See details»
Medexus Pharmaceuticals - Crunchbase Company Profile
Medexus Pharmaceuticals is a commercial platform providing products and services to differentiated companies with a portfolio of valuable orphan and rare disease products. …See details»
Medexus Announces Strong Fiscal Q2 2024 Results, Including …
Nov 8, 2023 About Medexus. Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative …See details»
Medexus Pharmaceuticals Announces Clear Path to FDA …
TORONTO and CHICAGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) …See details»
Medexus Announces Strongest Quarter in Company History with …
Nov 8, 2022 Medexus Pharmaceuticals Inc. Results reflect strong growth across all leading prescription products, including IXINITY, Rupall, and Gleolan. Management to …See details»
Org Chart Medexus Pharmaceuticals - The Official Board
The organizational chart of Medexus Pharmaceuticals displays its 11 main executives including Ken D'entremont, Marcel Konrad and Richard LabelleSee details»
Medexus Pharma - Crunchbase Company Profile & Funding
Medexus Pharma is a pharmaceutical company that offers products for rare diseases. They provide healthcare products that address a variety of diseases, including …See details»
Medexus Pharmaceuticals Inc. (MDP.TO) - Yahoo Finance Canada
Find the latest Medexus Pharmaceuticals Inc. (MDP.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Medexus Pharmaceuticals Company Description - Stock Analysis
5 days ago Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic …See details»
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal …
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (" Medexus " or the " Company ") (TSX: MDP) (OTCQX: …See details»
Health Canada Grants Authorization to Medexus …
Mar 6, 2019 Medexus Pharmaceuticals Inc. announced that Health Canada has authorized the Company to distribute Treosulfan, a conditioning agent used prior to stem cell …See details»
FDA Approves Medexus's Supplemental Biologics License …
Mar 26, 2024 Toronto, Ontario and Chicago, Illinois-- (Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced that the …See details»
Medexus Pharmaceuticals - Overview, News & Similar …
Nov 10, 2023 Who is Medexus Pharmaceuticals. Medexus Pharmaceuticals is a leading innovative and rare disease, pharmaceutical company with a strong North …See details»
Medexus Pharmaceuticals Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Medexus Pharmaceuticals Inc of Bolton, ON. Get the latest business insights from Dun …See details»
Medexus Pharma - Overview, News & Similar companies
Mar 1, 2022 Who is Medexus Pharma. Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform. The Company's vision is to …See details»
The Sage Group Announces $100M+ Transaction between …
The Sage Group Inc. served as exclusive advisor to medac GmbH on this $100M+ transaction. Medexus Pharmaceuticals and medac GmbH enter into a License …See details»
MEDXF Stock Price Quote | Morningstar
May 29, 2024 Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a …See details»
Is MDP stock a buy? (June, 2024) - Cantech Letter
5 days ago In a research update to clients June 6, Quenneville maintained his “Speculative Buy” rating, but raised his price target on the stock from $3.00 to $3.30, …See details»